<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00600405</url>
  </required_header>
  <id_info>
    <org_study_id>2958</org_study_id>
    <nct_id>NCT00600405</nct_id>
  </id_info>
  <brief_title>The Efficacy of Tamsulosin in the Treatment of Ureteral Stones in Emergency Department Patients</brief_title>
  <official_title>The Efficacy of Tamsulosin in the Treatment of Ureteral Stones in Emergency Department Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>MaineHealth</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Maine Medical Center Mentored Research Committee</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>MaineHealth</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the efficacy of the Î±-adrenergic antagonist&#xD;
      tamsulosin in the treatment of adult emergency department (ED) patients with ureteral colic&#xD;
      secondary to lower ureteral calculus. We hypothesize that there will be no difference in&#xD;
      outcomes for subjects treated with and without tamsulosin.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This prospective, randomized controlled trial seeks to compare outcomes for adult emergency&#xD;
      department patients with lower ureteral calculus. Subjects will be randomized to receive&#xD;
      treatment with ibuprofen and oxycodone alone (standard therapy) or standard therapy plus&#xD;
      tamsulosin 0.4mg orally once daily for ten days.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2006</start_date>
  <completion_date type="Actual">November 2007</completion_date>
  <primary_completion_date type="Actual">November 2007</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of spontaneous ureteral stone expulsion</measure>
    <time_frame>48, 120, 336 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to spontaneous ureteral stone expulsion.</measure>
    <time_frame>48, 120, 336 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-reported NRS-11 pain scores.</measure>
    <time_frame>48, 120, 336 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of colicky pain episodes.</measure>
    <time_frame>48, 120, 336 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of days missed work or usual functional ability.</measure>
    <time_frame>48, 120, 336 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of return ED visits or unscheduled PCP visits for continued pain.</measure>
    <time_frame>48, 120, 336 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Amount of narcotic pain medication used.</measure>
    <time_frame>48, 120, 336 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse medication-related events.</measure>
    <time_frame>48, 120, 336 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">81</enrollment>
  <condition>Nephrolithiasis</condition>
  <condition>Ureteral Calculi</condition>
  <arm_group>
    <arm_group_label>I</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects randomized to the experimental group receive ibuprofen, oxycodone, and tamsulosin 0.4 mg orally daily for ten days.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>II</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Standard therapy arm: subjects randomized to standard therapy receive ibuprofen and oxycodone alone.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>tamsulosin</intervention_name>
    <description>Tamsulosin 0.4 mg orally daily for ten days.</description>
    <arm_group_label>I</arm_group_label>
    <other_name>Flomax</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Standard therapy with ibuprofen and oxycodone.</intervention_name>
    <description>Oxycodone: 5mg, one to two tablets every four to six hours as needed for pain. Ibuprofen: 800 mg, one three times a day with food as needed for pain.</description>
    <arm_group_label>II</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18 years of age or older;&#xD;
&#xD;
          -  able to read, write, and speak English;&#xD;
&#xD;
          -  able to use the NRS pain scale; and&#xD;
&#xD;
          -  computed tomography diagnosed single lower ureteral calculus&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  allergy or sensitivity to the study drug (tamsulosin hydrochloride [Flomax]);&#xD;
&#xD;
          -  sulfa/sulfonamide allergy;&#xD;
&#xD;
          -  inability to provide informed consent;&#xD;
&#xD;
          -  lithiasis of the ureteral intramural tract;&#xD;
&#xD;
          -  acute or chronic renal failure;&#xD;
&#xD;
          -  fever;&#xD;
&#xD;
          -  presence of multiple ureteral stones;&#xD;
&#xD;
          -  peptic ulcer disease;&#xD;
&#xD;
          -  liver failure;&#xD;
&#xD;
          -  concomitant treatment with alpha-lytic drugs, calcium antagonists, nitrates, or&#xD;
             vardenafil (Levitra);&#xD;
&#xD;
          -  pregnancy;&#xD;
&#xD;
          -  breastfeeding; or&#xD;
&#xD;
          -  a history of urinary surgery or endoscopic treatment.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andrew D Perron, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>MaineHealth</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Maine Medical Center</name>
      <address>
        <city>Portland</city>
        <state>Maine</state>
        <zip>04102</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2008</verification_date>
  <study_first_submitted>January 14, 2008</study_first_submitted>
  <study_first_submitted_qc>January 14, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 25, 2008</study_first_posted>
  <last_update_submitted>January 14, 2008</last_update_submitted>
  <last_update_submitted_qc>January 14, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 25, 2008</last_update_posted>
  <responsible_party>
    <name_title>Andrew Perron, MD</name_title>
    <organization>Maine Medical Center</organization>
  </responsible_party>
  <keyword>Nephrolithiasis</keyword>
  <keyword>Ureteral Calculi</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nephrolithiasis</mesh_term>
    <mesh_term>Kidney Calculi</mesh_term>
    <mesh_term>Ureteral Calculi</mesh_term>
    <mesh_term>Ureterolithiasis</mesh_term>
    <mesh_term>Emergencies</mesh_term>
    <mesh_term>Calculi</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ibuprofen</mesh_term>
    <mesh_term>Oxycodone</mesh_term>
    <mesh_term>Tamsulosin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

